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Paraneoplastic Acral Vascular Syndrome
Daniel M. Kopolovich, MSIII, Dean D. Laganosky, MSIII, Allison A. Greco, MSIV,
Emma Weaver, MD, Rahul Malhotra, MD, Phoebe Holmes, MD, John Stewart, MD

Introduction
Cases of rheumatologic phenomena coinciding with malignancy
have been well-documented in the medical literature. These
syndromes may be associated with common autoimmune
markers, potentially masking the underlying diagnosis of
malignancy. The association between malignancy and its
coinciding rheumatologic manifestations is poorly understood.
These paraneoplastic symptoms are more prevalent in
high-stage adenocarcinomas of the lung, breast, and ovary.
Possible mechanisms may include cytokine derangements,
blood hyperviscosity, and circulatory disruption. While some
evidence suggests that control of the primary tumor alleviates its
associated paraneoplastic symptoms, other proposed therapies
include heparin, prednisone, aspirin, and vasodilatory agents.
Efficacy is limited due to association of these syndromes with
high-grade malignancy. We describe the case of a patient
presenting with paraneoplastic acral vascular syndrome (PAVS)
in association with primary ovarian carcimona.1,2

Case
The patient is a 57-year-old female with a history of Hashimoto’s
thyroiditis and migraines, who presents with an ulcerating rash
of the fingertips and a tender discoloration of the plantar aspect
of both feet. The rash began four weeks prior to presentation
as a purple discoloration of the fingertips, progressing to a
desquamating, palmar rash with distal phalangeal ulceration
and necrosis of the fingertips. Almost simultaneously, the
patient experienced purple discoloration of the soles of her feet
bilaterally and described a sensation of “standing on marbles.”
She denies similar episodes in the past as well as sick contacts.
She reports experiencing excessive stress in preparing for her
daughter’s wedding, exposure to a new type of dryer sheet, and
a recent manicure/pedicure. The patient was recently treated
with two medrol dose packs, minocycline, nitroglycerin paste
(which had to be discontinued due to hypotension), and aspirin.
Following treatment, the patient had no relief of symptoms.
Review of systems was remarkable for bilateral knee pain, painful
mouth ulcers, a non-tender, erythematous scaling rash on the
elbows, back, and right thigh. She denied fever, weight loss,
fatigue, night sweats, change in appetite, or abdominal swelling.
She reported allergies to DEET (rash and trouble breathing)
and Demerol. Recent skin testing suggested sensitivity to wheat,
corn, and soy. Family history was significant for a mother with
giant cell arteritis, father who passed away from melanoma and
a sister with breast cancer. The patient also had two daughters,
one with Raynaud’s syndrome and celiac disease, and another
with Sjogren’s syndrome. The patient was a middle school math
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teacher and had no occupational exposures. Social history was
unremarkable.

Physical Exam
Physical exam revealed unremarkable vital signs. The patient’s
right hand was notable for purple discoloration of the distal 2nd
through 5th digits and necrotic ulcerations of the distal 2nd and
3rd digits (Figure 1). The left hand had purple discoloration
of the distal 1st through 5th digits. Both hands had slight
peeling of the palmar surface, not extending past the wrist.
There was mild swelling of the metacarpal-phalangeal joints
as well as proximal inter-phalangeal joints bilaterally. Purple
discoloration of the anterior plantar surfaces of bilateral feet was
also noted. Neurologic exam was intact. Patient had 2+ radial,
posterior tibial and dorsalis pedis pulses bilaterally, and no leg
edema. Faint crackles were auscultated posteriorly in bilateral
lower lobes of the lungs. No cervical, supraclavicular, axillary or
inguinal lymphadenopathy was palpated.
Lab values revealed the following: C-Reactive Proteins 10.9 (H),
Rheumatoid Factor: 16.9 (H), ANA (homogenous 1:160, speckled
1:160), Anti-Ro 8.0 (H), Anti-cardiolipin IgM 76 (H), Aldolase
11.7 (H). CA-125 118 (H) CA 15.3 (CA 27.29) 46 (H). Blood

Figure 1. Right Hand Rash
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count, coagulation profile, chemistry profile, liver function tests,
lipid profile and urinalysis were unremarkable. Additionally,
ESR, Anti-double stranded DNA, Anti Scl-70, c-ANCA,
p-ANCA, atypical p-ANCA, anti-MPO, Antiproteinase-3, Jo-1
antibody, Lyme panel, viral hepatitis panel, EBV/CMV PCR,
cold agglutinins, SPEP/UPEP, beta-2 glycoprotein, Celiac panel,
Lupus anticoagulant, RNP, CPK, heavy metals, CEA, and CA
19.9 were also normal. Chest radiograph showed a pulmonary
interstitial prominence with predilection for the lung bases.
CT chest/abdomen/pelvis showed patchy ground glass opacities
bilateral lower lobes, likely airspace filling process, of uncertain
significance. No interstitial lung disease. Diffuse retroperitoneal
adenopathy, extending from the diaphragm down through the
common iliac and external iliac territories and a cystic area in
the left adnexa. Another lymph node in the right supraclavicular
region was also seen and a fine needle biopsy of this node was
performed. Cytology was consistent with an adenocarcinoma of
ovarian origin. (Figures 2 & 3)
MRI of the abdomen and pelvis revealed a 5.0 cm solid and
cystic left adnexal mass, lesions of the left ileum consistent with
bony metastases, and extensive peritoneal carcinomatosis.

Figure 2. Diff quick stain of fine needle aspiration of lymph node
showing large malignant cells consistent with adenocarcinoma.

Discussion
This patient was diagnosed with paraneoplastic acral vascular
syndrome (PAVS) in association with primary ovarian
carcinoma. PAVS is an infrequently described phenomenon
characterized by acrocyanosis and subsequent necrosis of the
distal extremities secondary to malignancy. Most common
associations are adenocarcinoma of gastrointestinal and
pulmonary origin; however, ovarian cancer has been implicated
in a number of cases.1,3-5 Of these, the majority are found to be
metastatic at the time of diagnosis.5,6 In one literature review it
was shown that PAVS affects the hands in 94% of patients and
the feet in only 30%.1 The mean age of onset is 54.4 years old and
vasculitis precedes the diagnosis of malignancy by an interval of
1-38 months with a mean of 10 months.3,7

Figure 3. Wilms immunohistochemical stain of the cell block–the
stain is positive, confirming an ovarian origin, ruling out lung.

A number of authors have previously described atypical features
that may raise suspicion for an underlying neoplastic versus
primary rheumatologic pathology. Age greater than 50 years at
presentation, atypical involvement of the digits, as well as poor
response to steroids and vasodilating agents may indicate an
underlying malignancy. In contrast to primary rheumatologic
disorders, which occur more frequently in young women, these
conditions occur with equal frequency in men and women.1,2

consistent between patients. In one study, the pathology of the
digits showed leukocytoclastic small vessels, which was histologically different from the vascular involvement normally seen in
other diseases such as Rheumatoid arthritis, SLE, and Takayasu
vasculitis.7 Fibrinoid necrosis and intimal proliferation were also
noted.8 Other findings included disruption of the endothelium
and invasion of the vessels by neutrophils.7

Several proposed mechanisms for PAVS include: (i) ischemia
from tumor antigen immune complex deposition in the small
vessels of the digits, (ii) tumor infiltration into the cervical
plexus resulting in the release of vasoconstrictor substances,
(iii) direct endothelium invasion by the tumor cells, and (iv)
hypersensitivity reaction.4,7 However, these mechanisms are not

Treatment options for addressing the symptoms of PAVS include
steroids, IV prostacyclin, lower molecular weight Heparin,
aspirin, topical nitroglycerin, and calcium channel blockers.
More definitively, PAVS was found to resolve with cancer
treatment.1 In another study of 22 patients, clinical remission of
malignancy corresponded with the disappearance of PAVS.6 In
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summary, small vessel disease refractory to traditional therapies
warrants increased clinical suspicion for metastatic malignancy
so as not to delay definitive treatment.
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